Thromboreductin
Recall
|
Medicines
|
01/09/2017
"AOP Orphan Pharmaceuticals AG" informed its supplied customers by letter dated August 31, 2017, that "Thromboreductin 1.0 mg Capsules" was placed on the market as a medicinal product not authorized in Austria in this strength with defective packaging, since the labeling and directions for use were not approved by the BASG.
Name of the medicinal product | Thromboreductin 1,0 mg Kapseln |
---|---|
Marketing authorisation number(s) | keine |
Marketing authorisation holder | Inverkehrbringer: AOP Orphan Pharmaceuticals AG |
Batch number(s) | E316A |
Classification of the recall | 2 |
BASG reference number | INS-640.001-2234 |
Further inquiry note
Page last modified:
12/07/2022